MEGAN REYNOLDS: Open Payments
NPI 1265976138 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,700 in 82 payments from 17 companies in 2025. Trend: 2023 $1,163 · 2024 $1,089 · 2025 $1,700
Food & beverage: $1,700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $433 |
| Madrigal Pharmaceuticals | 6 | $288 |
| Novo Nordisk Inc | 14 | $166 |
| Axsome Therapeutics, Inc. | 3 | $151 |
| Lundbeck LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 9 | $91 |
| Ardelyx, Inc. | 5 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| Abbott Laboratories | 3 | $63 |
Products named: REZDIFFRA, VRAYLAR, LINZESS, Auvelity, VYEPTI, VOQUEZNA, IBSRELA, Rybelsus.
Industry payments across KY — which companies pay providers there.
